Live Webinar: Overview of Psychedelic-Assisted Therapy for Mental Health
Psychedelic assisted therapy is emerging as a highly effective form of mental health treatment. This workshop will provide health care professionals an overview of this new clinical area. First, a history of the use of psychedelics will be reviewed that includes an appreciation for their long-standing use by many indigenous cultures. Differences between the most common psychedelics will be outlined, as well as their unique psychological and physical effects. Next, the two major waves of psychedelic research will be summarized, with emphasis on more recent and rigorous clinical trials. The basic model of psychedelic-assisted psychotherapy will be explained so that workshop participants will have a better sense of how this treatment works. The workshop will highlight the importance of preparation and integration, as well as how to use a harm reduction approach to provide therapeutic support to clients using psychedelics on their own. The current legal status of psychedelics will be reviewed, including Oregon’s developing a legal psilocybin-assisted therapy program which is serving as a model throughout the country. Finally, diversity issues around lack of access for underserved populations will be explored, as well as the prevalence of cultural appropriation and colonialism in modern psychedelic medicine.
Objectives for this course include:
-Participants will be able to describe the theory and practice of psychedelic assisted psychotherapy.-Participants will be able to summarize research findings and current legal status of psychedelic assisted psychotherapy. -Participants will be able to describe the role of psychotherapy in preparation for and integration of psychedelic experiences.
This course meets criteria for 3 hours of general continuing education by the Oklahoma Board of Behavioral Health for Oklahoma LPC and LMFT license holders, by the Oklahoma State Board of Licensed Social Workers (provider #20220088) for Oklahoma LCSW license holders, by the Oklahoma Board of Licensed Drug and Alcohol Counselors (certificate #20220018) for LADC and CADC license holders (3 hours non-specific CEUs), and for Oklahoma case managers (3 hours general CEUs).
Brian Pilecki, PhD
Brian Pilecki, PhD: Dr. Brian Pilecki is a clinical psychologist at Portland Psychotherapy that specializes in the treatment of anxiety disorders, trauma and PTSD, and psychedelic-assisted therapy. Brian practices from an orientation based in Acceptance and Commitment Therapy (ACT) and has extensive experience in the areas of mindfulness and meditation that he incorporates into therapy with clients. At Portland Psychotherapy, Brian is an active researcher and a study therapist on a clinical trial investigating the use of MDMA-assisted therapy for the treatment of social anxiety disorder and understanding processes of change in psychedelic therapy. He is a consultant and instructor for Fluence Training and co-chairperson for the Psychedelic Special Interest Group of the Association for Contextual Behavioral Science. He also co-hosts a podcast called Altered States of Context about the intersection of psychedelics and psychotherapy and is affiliate faculty at the Oregon Health and Science University. Brian is also a co-founder of Portland Integration Network, a network of professionals offering specialized care related to psychedelics in Oregon.